SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-021220
Filing Date
2024-06-26
Accepted
2024-06-26 08:16:11
Documents
18
Period of Report
2024-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20240625_8k.htm   iXBRL 8-K 36425
2 EXHIBIT 10.1 ex_692148.htm EX-10.1 241611
3 EXHIBIT 10.2 ex_692149.htm EX-10.2 101765
4 EXHIBIT 99.1 ex_692150.htm EX-99.1 16095
9 diamedicalogo.jpg GRAPHIC 6910
  Complete submission text file 0001437749-24-021220.txt   625589

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240625.xsd EX-101.SCH 3410
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240625_def.xml EX-101.DEF 11413
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240625_lab.xml EX-101.LAB 15291
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240625_pre.xml EX-101.PRE 11573
22 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240625_8k_htm.xml XML 2854
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 241070681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)